Loading…

Elevated plasma homocysteine leads to alterations in fibrin clot structure and stability: implications for the mechanism of thrombosis in hyperhomocysteinemia

Elevated plasma homocysteine is associated with an increased risk of atherosclerosis and thrombosis. However, the mechanisms by which homocysteine might cause these events are not understood. We hypothesized that hyperhomocysteinemia might lead to modification of fibrinogen in vivo, thereby causing...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of thrombosis and haemostasis 2003-02, Vol.1 (2), p.300-306
Main Authors:	Sauls, D. L., Wolberg, A. S., Hoffman, M.
Format:	Article
Language:	English
Subjects:	Animals Blood Coagulation cardiovascular disease Fibrin - metabolism Fibrin - ultrastructure fibrinogen Fibrinogen - isolation & purification Fibrinogen - metabolism Fibrinolysin - metabolism fibrinolysis homocysteine Homocysteine - blood Hyperhomocysteinemia - blood Hyperhomocysteinemia - complications In Vitro Techniques Microscopy, Electron, Scanning Rabbits thrombosis Thrombosis - blood Thrombosis - etiology
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

cited_by	cdi_FETCH-LOGICAL-c4293-c66c88282c95a8fc385330edcc6615369c2d2afd2797ebb682b453386048db553
cites	cdi_FETCH-LOGICAL-c4293-c66c88282c95a8fc385330edcc6615369c2d2afd2797ebb682b453386048db553
container_end_page	306
container_issue	2
container_start_page	300
container_title	Journal of thrombosis and haemostasis
container_volume	1
creator	Sauls, D. L. Wolberg, A. S. Hoffman, M.
description	Elevated plasma homocysteine is associated with an increased risk of atherosclerosis and thrombosis. However, the mechanisms by which homocysteine might cause these events are not understood. We hypothesized that hyperhomocysteinemia might lead to modification of fibrinogen in vivo, thereby causing altered fibrin clot structure. New Zealand White rabbits were injected intraperitoneally (i.p.) every 12 h through an indwelling catheter with homocysteine or buffer for 8 weeks. This treatment raised the plasma homocysteine levels to about 30 µmol L−1 compared with 13.5 µmol L−1 in control rabbits by the end of the treatment period. The fibrinogen levels were 3.2 ± 0.6 in homocysteine‐treated and 2.5 ± 1.1 mg mL−1 in control rabbits. The reptilase time was prolonged to 363 ± 88 for plasma from homocysteine‐treated rabbits compared with 194 ± 48 s for controls (P
doi_str_mv	10.1046/j.1538-7836.2003.00053.x
format	article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73487058</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>73487058</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4293-c66c88282c95a8fc385330edcc6615369c2d2afd2797ebb682b453386048db553</originalsourceid><addsrcrecordid>eNqNkc1u3CAUhVHUqvlpXyFi1d04GIyN01UUpU2iSN2ka4TxtYYRGBdwGr9MnjVMZppkmdUF7jnnivshhEtSlKSqzzZFyZlYNYLVBSWEFYQQzorHA3T02vj0_9wydoiOY9wQUracki_osKSiKTmpjtDTlYUHlaDHk1XRKbz2zuslJjAjYAuqjzh5rGyCoJLxY8RmxIPpQi7a-oRjCrNOcwCsxj7fVGesScs5Nm6yRu9Ngw84rQE70Gs1muiwH_JD8K7z0byErpcJwvvxzqiv6POgbIRv-3qC_vy8ur-8Xt39_nVzeXG30hVt2UrXtRaCCqpbrsSgmeCMEeh1buQl1K2mPVVDT5u2ga6rBe2qrBA1qUTfcc5O0Pdd7hT83xliks5EDdaqEfwcZcMq0RAuslDshDr4GAMMcgrGqbDIksgtG7mR27XLLQK5ZSNf2MjHbD3dz5g7B_2bcQ8jC37sBP-MheXDwfL2_jp_5hkOiqFl</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73487058</pqid></control><display><type>article</type><title>Elevated plasma homocysteine leads to alterations in fibrin clot structure and stability: implications for the mechanism of thrombosis in hyperhomocysteinemia</title><source>EZB Electronic Journals Library</source><creator>Sauls, D. L. ; Wolberg, A. S. ; Hoffman, M.</creator><creatorcontrib>Sauls, D. L. ; Wolberg, A. S. ; Hoffman, M.</creatorcontrib><description>Elevated plasma homocysteine is associated with an increased risk of atherosclerosis and thrombosis. However, the mechanisms by which homocysteine might cause these events are not understood. We hypothesized that hyperhomocysteinemia might lead to modification of fibrinogen in vivo, thereby causing altered fibrin clot structure. New Zealand White rabbits were injected intraperitoneally (i.p.) every 12 h through an indwelling catheter with homocysteine or buffer for 8 weeks. This treatment raised the plasma homocysteine levels to about 30 µmol L−1 compared with 13.5 µmol L−1 in control rabbits by the end of the treatment period. The fibrinogen levels were 3.2 ± 0.6 in homocysteine‐treated and 2.5 ± 1.1 mg mL−1 in control rabbits. The reptilase time was prolonged to 363 ± 88 for plasma from homocysteine‐treated rabbits compared with 194 ± 48 s for controls (P < 0.01). The thrombin clotting time (TCT) for the homocysteine‐treated rabbits was significantly shorter, 7.5 ± 1.7 compared with 28.6 ± 18 s for the controls (P < 0.05). The calcium dependence of the thrombin clotting time was also different in homocysteinemic and control plasmas. Clots from plasma or fibrinogen of homocysteinemic rabbits were composed of thinner fibers than control clots. The clots formed from purified fibrinogen from homocysteine‐treated rabbits were lyzed more slowly by plasmin than comparable clots from control fibrinogen. Congenital dysfibrinogenemias have been described that are associated with fibrin clots composed of thin, tightly packed fibers that are abnormally resistant to fibrinolysis, and recurrent thrombosis. Our results suggest that elevated plasma homocysteine leads to a similar acquired dysfibrinogenemia. The formation of clots that are abnormally resistant to fibrinolysis could directly contribute to the increased risk of thrombosis in hyperhomocysteinemia.</description><identifier>ISSN: 1538-7933</identifier><identifier>ISSN: 1538-7836</identifier><identifier>EISSN: 1538-7836</identifier><identifier>DOI: 10.1046/j.1538-7836.2003.00053.x</identifier><identifier>PMID: 12871504</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Science Inc</publisher><subject>Animals ; Blood Coagulation ; cardiovascular disease ; Fibrin - metabolism ; Fibrin - ultrastructure ; fibrinogen ; Fibrinogen - isolation & purification ; Fibrinogen - metabolism ; Fibrinolysin - metabolism ; fibrinolysis ; homocysteine ; Homocysteine - blood ; Hyperhomocysteinemia - blood ; Hyperhomocysteinemia - complications ; In Vitro Techniques ; Microscopy, Electron, Scanning ; Rabbits ; thrombosis ; Thrombosis - blood ; Thrombosis - etiology</subject><ispartof>Journal of thrombosis and haemostasis, 2003-02, Vol.1 (2), p.300-306</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4293-c66c88282c95a8fc385330edcc6615369c2d2afd2797ebb682b453386048db553</citedby><cites>FETCH-LOGICAL-c4293-c66c88282c95a8fc385330edcc6615369c2d2afd2797ebb682b453386048db553</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12871504$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sauls, D. L.</creatorcontrib><creatorcontrib>Wolberg, A. S.</creatorcontrib><creatorcontrib>Hoffman, M.</creatorcontrib><title>Elevated plasma homocysteine leads to alterations in fibrin clot structure and stability: implications for the mechanism of thrombosis in hyperhomocysteinemia</title><title>Journal of thrombosis and haemostasis</title><addtitle>J Thromb Haemost</addtitle><description>Elevated plasma homocysteine is associated with an increased risk of atherosclerosis and thrombosis. However, the mechanisms by which homocysteine might cause these events are not understood. We hypothesized that hyperhomocysteinemia might lead to modification of fibrinogen in vivo, thereby causing altered fibrin clot structure. New Zealand White rabbits were injected intraperitoneally (i.p.) every 12 h through an indwelling catheter with homocysteine or buffer for 8 weeks. This treatment raised the plasma homocysteine levels to about 30 µmol L−1 compared with 13.5 µmol L−1 in control rabbits by the end of the treatment period. The fibrinogen levels were 3.2 ± 0.6 in homocysteine‐treated and 2.5 ± 1.1 mg mL−1 in control rabbits. The reptilase time was prolonged to 363 ± 88 for plasma from homocysteine‐treated rabbits compared with 194 ± 48 s for controls (P < 0.01). The thrombin clotting time (TCT) for the homocysteine‐treated rabbits was significantly shorter, 7.5 ± 1.7 compared with 28.6 ± 18 s for the controls (P < 0.05). The calcium dependence of the thrombin clotting time was also different in homocysteinemic and control plasmas. Clots from plasma or fibrinogen of homocysteinemic rabbits were composed of thinner fibers than control clots. The clots formed from purified fibrinogen from homocysteine‐treated rabbits were lyzed more slowly by plasmin than comparable clots from control fibrinogen. Congenital dysfibrinogenemias have been described that are associated with fibrin clots composed of thin, tightly packed fibers that are abnormally resistant to fibrinolysis, and recurrent thrombosis. Our results suggest that elevated plasma homocysteine leads to a similar acquired dysfibrinogenemia. The formation of clots that are abnormally resistant to fibrinolysis could directly contribute to the increased risk of thrombosis in hyperhomocysteinemia.</description><subject>Animals</subject><subject>Blood Coagulation</subject><subject>cardiovascular disease</subject><subject>Fibrin - metabolism</subject><subject>Fibrin - ultrastructure</subject><subject>fibrinogen</subject><subject>Fibrinogen - isolation & purification</subject><subject>Fibrinogen - metabolism</subject><subject>Fibrinolysin - metabolism</subject><subject>fibrinolysis</subject><subject>homocysteine</subject><subject>Homocysteine - blood</subject><subject>Hyperhomocysteinemia - blood</subject><subject>Hyperhomocysteinemia - complications</subject><subject>In Vitro Techniques</subject><subject>Microscopy, Electron, Scanning</subject><subject>Rabbits</subject><subject>thrombosis</subject><subject>Thrombosis - blood</subject><subject>Thrombosis - etiology</subject><issn>1538-7933</issn><issn>1538-7836</issn><issn>1538-7836</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><recordid>eNqNkc1u3CAUhVHUqvlpXyFi1d04GIyN01UUpU2iSN2ka4TxtYYRGBdwGr9MnjVMZppkmdUF7jnnivshhEtSlKSqzzZFyZlYNYLVBSWEFYQQzorHA3T02vj0_9wydoiOY9wQUracki_osKSiKTmpjtDTlYUHlaDHk1XRKbz2zuslJjAjYAuqjzh5rGyCoJLxY8RmxIPpQi7a-oRjCrNOcwCsxj7fVGesScs5Nm6yRu9Ngw84rQE70Gs1muiwH_JD8K7z0byErpcJwvvxzqiv6POgbIRv-3qC_vy8ur-8Xt39_nVzeXG30hVt2UrXtRaCCqpbrsSgmeCMEeh1buQl1K2mPVVDT5u2ga6rBe2qrBA1qUTfcc5O0Pdd7hT83xliks5EDdaqEfwcZcMq0RAuslDshDr4GAMMcgrGqbDIksgtG7mR27XLLQK5ZSNf2MjHbD3dz5g7B_2bcQ8jC37sBP-MheXDwfL2_jp_5hkOiqFl</recordid><startdate>200302</startdate><enddate>200302</enddate><creator>Sauls, D. L.</creator><creator>Wolberg, A. S.</creator><creator>Hoffman, M.</creator><general>Blackwell Science Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200302</creationdate><title>Elevated plasma homocysteine leads to alterations in fibrin clot structure and stability: implications for the mechanism of thrombosis in hyperhomocysteinemia</title><author>Sauls, D. L. ; Wolberg, A. S. ; Hoffman, M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4293-c66c88282c95a8fc385330edcc6615369c2d2afd2797ebb682b453386048db553</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Animals</topic><topic>Blood Coagulation</topic><topic>cardiovascular disease</topic><topic>Fibrin - metabolism</topic><topic>Fibrin - ultrastructure</topic><topic>fibrinogen</topic><topic>Fibrinogen - isolation & purification</topic><topic>Fibrinogen - metabolism</topic><topic>Fibrinolysin - metabolism</topic><topic>fibrinolysis</topic><topic>homocysteine</topic><topic>Homocysteine - blood</topic><topic>Hyperhomocysteinemia - blood</topic><topic>Hyperhomocysteinemia - complications</topic><topic>In Vitro Techniques</topic><topic>Microscopy, Electron, Scanning</topic><topic>Rabbits</topic><topic>thrombosis</topic><topic>Thrombosis - blood</topic><topic>Thrombosis - etiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sauls, D. L.</creatorcontrib><creatorcontrib>Wolberg, A. S.</creatorcontrib><creatorcontrib>Hoffman, M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of thrombosis and haemostasis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sauls, D. L.</au><au>Wolberg, A. S.</au><au>Hoffman, M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Elevated plasma homocysteine leads to alterations in fibrin clot structure and stability: implications for the mechanism of thrombosis in hyperhomocysteinemia</atitle><jtitle>Journal of thrombosis and haemostasis</jtitle><addtitle>J Thromb Haemost</addtitle><date>2003-02</date><risdate>2003</risdate><volume>1</volume><issue>2</issue><spage>300</spage><epage>306</epage><pages>300-306</pages><issn>1538-7933</issn><issn>1538-7836</issn><eissn>1538-7836</eissn><abstract>Elevated plasma homocysteine is associated with an increased risk of atherosclerosis and thrombosis. However, the mechanisms by which homocysteine might cause these events are not understood. We hypothesized that hyperhomocysteinemia might lead to modification of fibrinogen in vivo, thereby causing altered fibrin clot structure. New Zealand White rabbits were injected intraperitoneally (i.p.) every 12 h through an indwelling catheter with homocysteine or buffer for 8 weeks. This treatment raised the plasma homocysteine levels to about 30 µmol L−1 compared with 13.5 µmol L−1 in control rabbits by the end of the treatment period. The fibrinogen levels were 3.2 ± 0.6 in homocysteine‐treated and 2.5 ± 1.1 mg mL−1 in control rabbits. The reptilase time was prolonged to 363 ± 88 for plasma from homocysteine‐treated rabbits compared with 194 ± 48 s for controls (P < 0.01). The thrombin clotting time (TCT) for the homocysteine‐treated rabbits was significantly shorter, 7.5 ± 1.7 compared with 28.6 ± 18 s for the controls (P < 0.05). The calcium dependence of the thrombin clotting time was also different in homocysteinemic and control plasmas. Clots from plasma or fibrinogen of homocysteinemic rabbits were composed of thinner fibers than control clots. The clots formed from purified fibrinogen from homocysteine‐treated rabbits were lyzed more slowly by plasmin than comparable clots from control fibrinogen. Congenital dysfibrinogenemias have been described that are associated with fibrin clots composed of thin, tightly packed fibers that are abnormally resistant to fibrinolysis, and recurrent thrombosis. Our results suggest that elevated plasma homocysteine leads to a similar acquired dysfibrinogenemia. The formation of clots that are abnormally resistant to fibrinolysis could directly contribute to the increased risk of thrombosis in hyperhomocysteinemia.</abstract><cop>Oxford, UK</cop><pub>Blackwell Science Inc</pub><pmid>12871504</pmid><doi>10.1046/j.1538-7836.2003.00053.x</doi><tpages>7</tpages></addata></record>
fulltext	fulltext
identifier	ISSN: 1538-7933
ispartof	Journal of thrombosis and haemostasis, 2003-02, Vol.1 (2), p.300-306
issn	1538-7933 1538-7836 1538-7836
language	eng
recordid	cdi_proquest_miscellaneous_73487058
source	EZB Electronic Journals Library
subjects	Animals Blood Coagulation cardiovascular disease Fibrin - metabolism Fibrin - ultrastructure fibrinogen Fibrinogen - isolation & purification Fibrinogen - metabolism Fibrinolysin - metabolism fibrinolysis homocysteine Homocysteine - blood Hyperhomocysteinemia - blood Hyperhomocysteinemia - complications In Vitro Techniques Microscopy, Electron, Scanning Rabbits thrombosis Thrombosis - blood Thrombosis - etiology
title	Elevated plasma homocysteine leads to alterations in fibrin clot structure and stability: implications for the mechanism of thrombosis in hyperhomocysteinemia
url	http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T21%3A37%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Elevated%20plasma%20homocysteine%20leads%20to%20alterations%20in%20fibrin%20clot%20structure%20and%20stability:%20implications%20for%20the%20mechanism%20of%20thrombosis%20in%20hyperhomocysteinemia&rft.jtitle=Journal%20of%20thrombosis%20and%20haemostasis&rft.au=Sauls,%20D.%20L.&rft.date=2003-02&rft.volume=1&rft.issue=2&rft.spage=300&rft.epage=306&rft.pages=300-306&rft.issn=1538-7933&rft.eissn=1538-7836&rft_id=info:doi/10.1046/j.1538-7836.2003.00053.x&rft_dat=%3Cproquest_cross%3E73487058%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4293-c66c88282c95a8fc385330edcc6615369c2d2afd2797ebb682b453386048db553%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=73487058&rft_id=info:pmid/12871504&rfr_iscdi=true